XML 58 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Description of Business and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2024
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

Following is a summary of cash, cash equivalents and restricted cash at December 31, 2024 and December 31, 2023:

 

(in thousands)  December 31,
2024		   December 31,
2023		 
Cash and cash equivalents  $72,904   $76,677 
Restricted cash – long-term   324    313 
Cash, cash equivalents and restricted cash  $73,228   $76,990 
Schedule of Diluted Net Loss Per Share

For the years ended December 31, 2024 and 2023, the Company’s potentially dilutive shares, which include outstanding common stock options, restricted stock units and warrants, have not been included in the computation of diluted net loss per share as the result would have been anti-dilutive. 

 

(in thousands)  December 31,
2024		   December 31,
2023		 
Stock Options   5,137    5,445 
Restricted Stock Units   300    305 
Warrants   7    1,442 
Total   5,444    7,192